Tanjoni et al. [37] synthesized a series of PROTACs based on CRBN ligand and FAK inhibitor PND-1186, linked by CRBN and PEG moieties that inhibited tumor growth in 4T1 and ID8 mice models. Here, PTK2 is linked to neoplasm.